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Abstract
Purpose To obtain detailed information on the outcomes of
patients with rheumatoid arthritis (RA) undergoing reverse
shoulder arthroplasty (RSA)
Methods A literature search was conducted for studies
reporting on the use of RSA in RA patients from 1990 to
2014. The inclusion criteria were a report of sufficient infor-
mation on pre-operative status and surgical outcome allowing
evaluation of the therapeutic potential of RSA in RA. The
literature search resulted in 586 hits, but only five studies that
met the inclusion criteria were assessed.
Results There were 100 shoulders that had been operated on,
of which 87 were followed for a mean of 55.4 months, the
longest follow-up being 11.9 years Most patients had
glenohumeral erosive lesions of Larsen Grade III or IV. The
Delta III prosthesis was implanted in most cases and in three
studies bone graft was used for severe glenoid lesions. The
main outcome measures employed were the Constant score
(Cs) and ASES questionnaire. The mean increase in Cs and
ASES score after surgery was 42.4 and 54 points, respectively.
The mean post-operative forward elevation was 120.6°, the
average increment being 51° and the mean increase of abduc-
tion was 58.5°. Themean prevalence of scapular notching was
35.4 %. The rate of adverse events was 31 %, but the vast
majority were of minor severity. Eight prostheses underwent
revision, due to infection in four.
Conclusions RSA implanted in RA patients would appear to
give similar results to those obtained inmassive cuff tears with
or without arthropathy.
Keywords Reverse shoulder athroplasty . Reverse shoulder
prosthesis . Rheumatoid arthritis . Outcomes . Revisions
Introduction
In the 1970s to 1990s, the surgical treatment for patients with
rheumatoid arthritis (RA) needing an arthroplasty was a
hemiarthroplasty (HA) or total shoulder arthroplasty (TSA)
[1]. However, in the long-term, patients with HA have
worsening of arm function if a large cuff tear occurs or
an already present tear increases in size due to destructive
changes of periarticular soft tissues inherent to RA. In
these cases, progressive anterosuperior instability of the
implant may occur [2]. This results in loss of varying
severity of active shoulder motion and in destructive
changes of the humeral head and glenoid, which overlap
possible erosive bone changes that RA entails. It was
found, in fact, that 48 % of rheumatoid patients followed
for 15 years develop even severe glenohumeral erosive
changes [3]. On the other hand, when a TSA is implanted,
there is a high risk of glenoid loosening in the presence of
a massive cuff tear [4].
With the advent of the reverse shoulder arthroplasty (RSA)
[5], rheumatoid patients with pain and severe shoulder
dysfunction resulting from massive cuff tear began to be
treated with RSA due to its ability to decrease shoulder
pain and restore arm motion in the absence of a functioning
rotator cuff. However, little is yet known on the outcomes of
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RSA in rheumatoid patients because a limited number of cases
appear to have been treated with reverse prosthesis. Further-
more, the numerous studies assessing the results of RSA in-
cluded no rheumatoid patients or, when they were present, no
or only scant information was provided on their outcomes.
This review was aimed at providing detailed information
on the various aspects of treatment of rheumatoid patients
undergoing RSA.
Materials and methods
Literature search
This review was performed according to the PRISMA state-
ment [6] (Fig. 1). A search of the literature was conducted by
two independent reviewers (S.C., G.C.) in Pubmed, EMBASE
and Cochrane Central Register of Controlled Trials to identify
relevant publications from 1990 to 2014.
The following keywords were used: shoulder prosthesis,
hemiarthroplasty, reverse, inverse, delta, Grammont arthroplasty,
total shoulder prosthesis or arthroplasty, rheumatoid arthritis,
outcomes, complications, revisions, infections. The Medline
and EMBASE search was performed by using combinations
of the selected keywords.
Criteria of inclusion
The studies had to provide sufficient information on RSA in
patients with RA, in terms of pre-operative conditions and
outcomes of surgery. The reported cases in each study had to
be not less than three. The mean follow-up should be at least
36 months, provided that the longest was carried out at a
minimum of five years. This decision was taken because the
intra-operative or early post-operative complications were in-
dependent of the length of follow-up, whereas those related to
implant, such as wear of loosening, might depend on the
length of follow-up. The studies had to provide the results
using one or more widely employed outcome measures
assessing pain and shoulder function and to include the pre-
operative and post-operative data.
Study selection
A total of 586 citations were screened. The titles were selected
to identify studies dealing with: (1) reverse or inverse shoulder
prosthesis or arthroplasty in rheumatoid arthritis; (2) shoulder
arthroplasty (RSA or TSA) in patients undergoing surgery for
various aetiologies; these publications were selected because
their patient populations might include cases with RA who
had had RSA.
The abstracts of 112 publications were assessed, but 72
were excluded because they were not eligible for our review.
A full-text article was retrieved for 40 studies (Fig. 1). Of the
latter, 33 were excluded. In 19 reporting on patients who had
undergone RSA or TSA, there were no rheumatoid patients
with RSA [7–25]; nine studies on patients who had had an
RSA for various aetiologies included one or more rheumatoid
patients, but no or insufficient information was provided on
their outcomes [26–34]; three review articles on RSA in pa-
tients with various conditions gave very little information,
contained in a short paragraph [35, 36], or limited information
[37], for the RA group; there were also two articles of general
information on shoulder arthroplasty reporting no own case
series [38, 39]. Two additional studies reported enough perti-
nent and useful information on several [40] or many [41] RA
patients undergoing RSA, but they were excluded because
the mean follow-up was less than 36 months and the
longest did not reach five years. This review was thus
based on the five studies that met the inclusion criteria
[42–46]: all dealing exclusively with RA patients.
Data extraction
A checklist was used to extract data from each study that met
the inclusion criteria. The data included the number, age and
gender of patients, number of shoulders undergoing
arthroplasty, number of patients followed-up and the mean,
and range of, follow-up. The clinical outcome measures andFig. 1 Flow chart of the search for studies that met the inclusion criteria
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the grade of the rheumatoid changes of the involved shoulder
were recorded. Surgical approach, type of RSA implanted, use
of bone graft and intra-operative complications, as well as
rehabilitation protocols and post-operative radiographic find-
ings were also recorded. The protocol included the clinical
results based on the outcome measures, degrees of shoulder
motion, post-operative complications including implant wear
or loosening and revision surgeries.
Selection or exclusion bias
In all studies selected, the mean age of patients was similar as
was, for the majority, the ratio of females to males. All were
case series with no comparison group. In three studies a single
outcome measure, the Constant and Murley score [47] (Cs),
was used. In one, three measures, including the Cs, were
employed and in another the American Society of Elbow
Surgeons (ASES) system was adopted. The percentage of
cases (operated-on shoulders) lost to final follow-up
ranged from 12 to 23 %. It thus appeared that there was
no or only minor potential for selection or exclusion bias
in the review.
Results
Demographic and pathological data
The demographic data of the cohorts of patients, total number
of patients and length of follow-up are reported in Table 1.
The number of patients included in the review was 91 and
the number of operated-on shoulders was 100, of which
87 were followed-up. The total mean follow-up of the five
studies was 46.4 months, i.e. slightly less than five years,
including two studies [43, 45] in which the latest follow-up
was carried at nine and 11.9 years after surgery, respectively
(Table 1).
All 91 patients had RA associated with cuff tears of varying
size. The vast majority had full-thickness tears of two cuff
tendons or massive irreparable tears and destructive changes
of the shoulder joint. In three studies [42–44] the erosive le-
sions were graded according to the classification of Larsen
et al. [48], which distinguishes six grades (0-V). The majority
of patients had lesions of Larsen Grade III or IVand a minority
of Grade II or V. In two studies the joint changes were
assessed using the Lévigne classification [49], which iden-
tifies six types (C1, C2, A1, A2, D1, D2) indicating pro-
gressive severity of lesions: in one [45] most patients had
Type C2 or A1 lesions and in the other [46] the majority
had Type A1 or A2. In the only report [44] in which
upward migration of the humeral head with respect to
the glenoid was assessed pre-operatively, most patients
had subluxations of 0–25 % or 25–50 %.
Surgical technique and types of RSA
In almost all cases the deltopectoral approach was carried out,
whereas in three patients of one study [42] a transacromial
approach was performed and in most primary arthroplasties
of another cohort [45] a superior deltoid splint was used.
The Delta III prosthesis (DePuy, Warsaw, IN, USA) was
implanted in all cases of the two oldest studies [42, 43], an
Aequalis (Tornier, Amsterdam, The Netherlands) in one [46]
and a DJO prosthesis (DJO Surgical, Vista, CA, USA) in
another one [44]. Ekelund and Nyberg [45] initially implanted
the Delta III and subsequently the Delta Xtend. In two studies
[45, 46] the glenoid baseplate was placed, when possible, in a
low position. The size of the glenosphere was mostly 36 mm.
In most studies the humeral stemwas cemented and implanted
in 0–30° of retroversion, but mostly in 0 or 10°.
In three studies [44–46], patients who had severe defects of
the central glenoid or peripheral erosions underwent bone
grafting. The graft was either cancellous or structural. Both
types were obtained from the resected humeral head or a
Table 1 Demographic data, number of patients and operated shoulders, patients followed-up and length of follow-up
Reference Age Gender Operated-on
patients (n)
Operated-on
shoulders (n)
Shoulders
followed-up (n)
Follow-up (months)
Mean Range M F Mean Range
Riitmeister [42] (2001) 60.2 34–86 2 6 7 8 8 54 48–73
Woodruff [43] (2003) 64 43–72 1 14 15 17 13 87 60–110
Holcomb [44] (2010) 70.4 53–80 5 16 24 24 a21 36 24–74
Ekelund [45] (2011) 68 45–80 7 22 29 33 b27 56 18–143
Young [46] (2011) 70.1 46–86 2 14 16 18 18 44 25–84
Total 91 100 87 55.4 18–143
a 18 primary RSA and 3 revisions of HA, TSA or bipolar HA to RSA
b 18 primary RSA and 9 revisions of HA or TSA to RSA, NR, value not reported
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structural allograft was used [45]. The cancellous bone was
impacted in the central portion of the glenoid for central
defects. Structural grafts were also used for central defects,
but were more often employed to reconstruct peripheral
defects. They were temporarily stabilised with K wires
and definitively secured using the screws employed for
fixation of the glenoid baseplate [45]. Occasionally, inde-
pendent cannulated screws were used [44].
Postoperative rehabilitation
Holcomb et al. [44] immobilised the patients in adduction and
internal rotation for 6 weeks, after which the activities of daily
living were permitted. Other authors [46] allowed passive mo-
tion immediately after surgery, but prescribed the use of a
sling for 1 month. Ekelund and Nyberg [45], when using the
deltopectoral approach, permitted immediate active motion,
but did not allow efforts with the operated-on shoulder for
six weeks.
Clinical outcomes
Six outcome measures were used (Table 2). The most
employed was the Cs method (0–100 score), utilised in four
studies [42, 43, 45, 46]. The next most used were the VAS
(visual analogue scale) followed by the ASES (American
Shoulder and Elbow Surgeons) questionnaire (0–50 score
for each of the two sections) the SST (simple shoulder test)
(one sectionwith 12 questions, and onewith 6 and 15 questions)
and SSV (simple shoulder value) (0–100 score) employed in
two studies.
In the studies using the Cs (Table 2), the mean pre-
operative score ranged from 3 [45] to 22 [46] with a mean
of 17.1 points and the post-operative scores from 52 [45] to 64
[46], with a mean of 59.5, the average increase being 42.4
points. The most recent studies [45, 46] reported statistically
significant differences between the pre-operative and post-
operative scores. Holcomb et al. [44] provided the total ASES
mean score, which increased on average from 28 pre-
operatively to 82 post-operatively, with a mean increment of
54 points. They also used the ASES pain and ASES function,
and VAS pain and VAS function scales. The former increased
by 30 points on average, parallel to the mean decrease in VAS
pain of 6 points, and the mean ASES function increased on
average by 24 points, whereas the VAS function improved by
3 points. The differences were significant for all outcome
measures.
The SST, used by Holcomb et al. [44], increased on aver-
age by 6 points after surgery. The mean SSV was 85 after
primary arthroplasty and 64 after revision surgery in the
Ekelund and Nyberg study [45].
Shoulder range of motion (ROM) was reported in detail in
the three most recent studies [44–46]. One of the oldest studies
[42] reported the scores obtained in the ROM section (0–40
points) of Cs method, whereas in the other [43] no specific
information was provided (Table 3).
In the most recent studies, the pre-operative flexion ranged
from 33 to 77°, mean 69.6°, and the post-operative motion
from 101 to 138°, with a mean of 120.6°, the average incre-
ment being 51°. Pre-operatively the mean range of abduction
was 26–65°, on average 49.7°, and post-operatively it ranged
from 95 to 119°, with a mean of 108.2°, the increase reaching
58.5° on average. In all three studies the differences for both
motions were significant. Comparable values for external ro-
tation (ER) were reported in two studies [44, 46], because one
[45] provided the degrees of movement based on the points
obtained in the ROM section of the Cs. Of the former two
studies, one [46] assessed the degrees of motion both with
the arm at the side and at 90° of abduction. Before surgery
the mean ER was 19° [44] and 15° [46] with the arm at the
side and 16 at 90° of abduction. After surgery, the average ER
with the arm at the side was 19 and 45°, respectively, mean of
Table 2 Mean value and (range) of outcome measures used for assessment of clinical results
Riitmeister [42] Cs
Pre 17 (4–25)
Post 63 (41–79)
Woodruff [43] Cs
Pre 17 (4–25)
Post 59 (37–86)
Holcomb [44] ASES Total
Pre 28 (5–65)
Post 82 (23–100)
ASES pain
Pre 15 (2–42)
Post 45 (0–50)
ASES function
Pre 13 (0–30)
Post 37 (8–50)
VAS pain
Pre 7 (1–9)
Post 1 (0–10)
VAS function
Pre 3 (0–9)
Post 6 (0–10)
SST
Pre 1 (0–2)
Post 7 (0–12)
Ekelund [45] Cs
Pre 3 (2–34)
Post 52 (15–77)
VAS
Pre 8 (4–10)
Post 1 (0–9)
SSV
85 ± 16 pimary surgery
64 ± 26 revision surgery
Young [46] Cs
Pre 22 (8–47)
Post 64 (28–85)
Cs Constant score, ASES American shoulder elbow surgeons (score), VAS visual analogue scale, SST simple shoulder test, SSV simple shoulder value
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32.3°, the average increase being 10.3°, whereas with the arm
in abduction the mean increment reached 30°. As for the in-
ternal rotation (IR), in two investigations [44, 46] the post-
operative mean increment was 2 and 3 levels, respectively,
and in the study which calculated the movement based on
Cs, the mean increment was approximately of 1 point. In the
Riitmeister and Kerschbaumer study [42], who provided the
entire shoulder ROM as points obtained in the Cs, there was a
mean increment of 22.7 points post-operatively (Table 3).
In three series [42, 44, 46], including 45 cases, the subjec-
tive outcome of surgery was considered excellent or good by
77.7 % of patients, satisfactory by 17.7 % and unsatisfactory
by 2.2 % (Table 3).
Radiographic results
Scapular notching was detected in two studies [45, 46]
(Table 4). In one [45], the notching was assessed according
to Nerot’s classification [49], whereas the other used the
Sirvaux’s classification [50]. Both classifications identify 5
grades of notching. The mean prevalence in these studies
was 53.6 %. The majority of shoulders for which the Nerot
classification was used had notching Grade 3 or 4. In the study
using the Sirvaux classification, most shoulders had Grade 1
or 2. Both studies found the scapular notching not to affect the
clinical outcome. Holcomb et al. [44], however, detected no
notching in the 21 shoulders that they followed-up. The over-
all prevalence of notching was thus 35.4 %.
In the three series [44–46], in which bone graft was impact-
ed on the glenoid, the graft healed with certainty [46] or pre-
sumably healed since no contrary information was provided
for the other two series.
Complications, reoperations other than revisions,
and revisions
Adverse events, of minor or major severity, were recorded in
31 of the 100 operated-on shoulders.
There were seven intraoperative complications [43–46]
(Table 5), i.e. 7% of operated-on shoulders. Themost frequent
was a fracture of the glenoid, which occurred in three patients,
the cause of which, however, was reported only for one case
[45], in which the fracture occurred during reaming of the
glenoid, without preventing implantation of the glenoid
baseplate. Another glenoid fracture required osteosynthesis
with a screw, which allowed stable fixation of the glenoid
baseplate. The remaining four complications occurred in the
patients of a single study [46]. They included an avulsion
fracture of the coracoid process, repaired with non-
absorbable sutures, two avulsions of the greater tuberosity
identified on immediate post-operative radiographs that did
Table 3 Mean (range) pre-operative and post-operative motions, and patient’s satisfaction
Reference FE ABD ER IR Subjective outcome
(no. of patients)Preop Preop Preop Preop
Postop Postop Postop Postop
Riitmeister [42]a 5.3 (0–8) 6 satisfactory
28 (16–36)
Woodruff [43] NR NR NR NR NR
Holcomb [44] 52° (10–87°) 55° (10–93°) 19° (−5 to 90°) S1 12 excellent
126° (0°–180°) 116° (0°–180°) 33° (−10 to 75) L4 6 good
2 satisfactory
1 unsatisfactory
Ekelund [45] 33° (0–110°) 26° (0–80°) b0.6 ± 1.2 b2.1 ± 2.2 NR
115° (0–160°) 103° (20–180°) 5.8 ± 3.0 2.9 ± 2.4
Young [46] 77° (30–170°) NR Arm at side Sacrum (thigh-T10) 11 excellent
138° (40–170°) NR 15° (−10° to 80°) L3 (buttock-T7) 6 good
19° (0–80°) 1 unsatisfactory
SSV mean 68 (20–100)
Arm at 90°
16° (−10 to 80°)
46° (0–90°)
FE forward elevation, ABD abduction, ER external rotation, IR internal rotation, Preop preoperative, Postop post-operative, NR value not reported, SSV
simple shoulder value
aMovements assessed all together according to points in the Constant score
bMovement assessed according to points in the Constant score
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not require further surgery and an axillary nerve neuroapraxia
which recovered in 4 months.
The 13 post-operative complications (14.9 %) included
fractures, glenoid radiolucencies and aseptic glenoid loosen-
ing (Table 5). Of the three fractures, two involved the scapular
spine and one the acromion [44, 46]. Both scapular injuries,
although causing prolonged pain and limitation of abduction,
were treated conservatively. The acromial fracture resulted in
inferior tilt of the fragment, but the patient had no dysfunction.
Three periglenoid radiolucencies and one aseptic glenoid
loosening underwent no specific treatment.
Re-operations were carried out in the three patients of
the Riimeister and Kerschbaumer series [42] in whom a
transacromial approach had been performed (Table 5).
They had failure of fixation and underwent repeat osteosynthesis
of the acromion.
Arthroplasty revisions (Table 5) were carried out in eight
shoulders (9.1 %). One patient with periprosthetic glenoid
fracture, resulting from a fall, underwent internal fixation of
the fracture and revision to hemiarthroplasty [44]. One of the
patients with aseptic glenoid loosening had replacement of the
glenoid component [42]. Of the four patients with infection,
one underwent debridement and exchange of the humerus
socket with no recurrence of infection [44] and one pa-
tient, who developed the infection six years after RSA,
had removal of the prosthesis and implantation of a
cemented hemiarthroplasty spacer [44]. Another patient,
who had undergone RSA for revision of a failed TSA,
required revision to a second RSA [45]. In the fourth of the
infected cases, the prosthesis was removed [42]. In one pa-
tient, who started to have prosthetic instability five years after
surgery due to wear of the polyethylene insert; a new retentive
insert was implanted with no subsequent instability [45]. One
shoulder that had breakage of the central screw connecting the
glenosphere to the glenoid baseplate underwent replacement
of the glenoid component [45].
Discussion
This review has several limitations. A limited number of stud-
ies has been published on RSA in RA, only few met the
criteria to be included in the review and one of them [42]
reported a small number of cases. A few studies provided
Table 4 Prevalence of scapular
notching 12 shoulders [45] out of 23 checked (52 %) Nerot Grade: 1–2 in 1; 3 in 7; 4 in 4
10 shoulders [46] out of 18 (55 %) Sirveaux Grade: 1 in 4; 2 in 4; 3 in 1; 4 in 1
No shoulders [44] out of 21 checked (0 %)
Percentage calculated on the number of cases followed-up
Table 5 Complications, re-
operations other than revisions
and revisions
Complications
Intraop. 7 % (100 Op. Sh.) Postop., with no further surgery 14.9 % (87 Sh. FU)
Fracture Fracture
Glenoid 3 [43, 44, 45] Scapular spine 2 [44, 46]
Coracoid 1 [46] Acromion 1 [46]
GT 2 [46] Glenoid 1 [46]
Nerve injury 1 [46]
Glenoid radiolucencies 3 [43]
Aseptic glenoid loosening 6 [42, 43]
Reoperations 2.7 % (87 Sh. FU)
Osteosynthesis of acromion after transacromial approach 3 [42]
Revisions 9.1 % (87 Sh. FU)
Periprosthetic glenoid Fx, osteosyntesis and HA 1 [44]
Aseptic glenoid loosening, exchange glenoid 1 [42]
Infection, exchange polyethylene humerosocket 1 [44]
Infection, cemented HA spacer 1 [44]
Infection after revision of TSA, new RSA 1 [45]
Infection, prosthesis removed 1 [42]
Humerus socket wear, exchange of insert 1 [45]
Breakage glenosphere screw, exchange of glenoid 1 [45]
FU followed-upIntraop. intraoperative, Postop. postoperative, Op. operations, Sh. shoulders
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incomplete information on the pre-operative and post-
operative functional status. The length of follow-up in some
reports was relatively short for the assessment of survivorship
of an RSA, although the mean follow-up of the whole group
reached almost five years and in two studies [43, 45] a few
patients were followed for approximately nine and 12 years,
respectively. Nevertheless, this review appears to be valuable
because it allowed assessment of the outcome of 87 shoulders
out of the 100 that underwent RSA in a condition for which
little is known on the outcomes of the reverse prosthesis.
Guery et al. [28] stated that extreme caution is needed
regarding the use of RSA in patients with RA because they
have the highest percentage of implant revisions, which were
two, both due to infection, in the eight rheumatoid cases in
their series. Similarly, Favard et al. [27] found the post-
operative Cs and functional improvement to be significantly
poorer in cases with RA than in those operated on for other
aetiologies. However, of the 18 rheumatoid patients in their
series, only six had undergone RSA; the remaining 12 had
TSA or HA and the authors do not specify whether the poor
results were found in those with RSA or also in the other
rheumatoid patients. Nevertheless, the statements in these
two studies have generated concern about the use of RSA in
rheumatoid patients.
In the four studies of this review that used the Cs as out-
come measure [42, 43, 45, 46], the mean score increased from
17.1 to 60.7, with a mean increment of 42.4 points. Such
increase compares well with the mean total ASES score
[44], which reached 82 points post-operatively, with a mean
increase of 54 points. Shoulder pain showed a considerable
improvement, as reflected by VAS pain scores reported in two
studies [44, 45], in which there was a mean decrement of 7 and
6 points, respectively. As for function, in the studies that re-
ported the pre-operative and post-operative ROM [44–46], the
arm flexion increased on average by 51° and the abduction by
58.5°. The results found in this review, in terms of mean
scores in the outcome measures, arm flexion and abduction,
and pain relief, are similar to those in studies analysing the
results of RSA in large cohorts of patients withmassive rotator
cuff tear or cuff tear arthropathy (CTA). In the series of 80
shoulders of Sirveaux et al. [51], the mean Cs increased by 43
points and the flexion by 65°. In the cohort of Frankle et al.
[13], the mean total ASES score improved by 33.9 points, the
VAS score for pain by 3.3 points, and the mean flexion and
abduction by 50,1 and 59.6°, respectively. Wall et al. [34], in a
cohort of 103 shoulders followed for a mean of 39.9 months,
found a mean improvement in Cs of 39.5 points. In 71 shoul-
ders undergoing RSA for CTA assessed by Nolan et al. [52]
the Cs improved by 34 points, the ASES score by 50 points
and the SSV was 77, on average, whereas the mean flexion
increased by 60° and ER did not change. Of the 45 patients of
this review for whom the subjective outcome of surgery was
reported [42, 44, 46], 77 % considered their results as
excellent or good. This rate is comparable to that obtained
recorded in several studies in which the RSAwas mostly im-
planted for massive cuff tears or CTA [10, 13, 31, 51].
In one study of this review [45] in which there were three
revisions (out of 23 shoulders), post-operatively the revised
cases had a mean Cs of 43 and a mean SSV of 64 points
compared to 57 and 84 points, respectively, of the patients
with primary arthroplasty. This finding is consistent with the
lower mean Cs found in patients with different conditions than
RA who underwent revision of HA or TSA to RSA [11, 34,
50, 53] compared with those who had RSA as primary
arthroplasty.
The mean prevalence of scapular notching was 35 %,
which is similar to the percentages reported in several studies
[13, 31, 33, 34] in which the rate ranged from 43 to 51 %, and
lower than the 68 % found by Boileau et al. [9]. As in other
studies [30, 33], the notching did not appear to affect the
clinical outcome.
In a comprehensive review of the literature on complica-
tions of RSA, Scarlat [54] described 20 types of complica-
tions, that he classified into four categories, and analysed the
causes and possible solutions for some of them. In our review,
in which many of those situations were found, we distin-
guished three types of adverse events, identified as complica-
tions, re-operations other than revisions, and revisions. The
scapular notching was not included among the adverse events
because it is not peculiar of TSA in RA and appears to depend,
to a large extent, on the height of implantation of the
glenosphere and/or the use of a concentric, rather than the
more recent eccentric, glenosphere [55].
The mean rate of adverse events in the studies of this re-
view was 32 %, which is comparable to the 33.3 % found by
Zumstein et al. [53] in a review of 782 cases of RSA carried
out for various aetiologies.
Many of those that we termed complications were adverse
events of minor severity, requiring no surgery and mostly not
affecting the clinical outcome. The vast majority were intra-
operative or post-operative fractures related to the increased
bone fragility of the rheumatoid patients.
The re-operations other than revisions were performed in
three patients operated on in the 1990s when a transacromial
approach was used by many surgeons, but subsequently al-
most completely abandoned.
The major complications needing arthroplasty revision
were 7.4 %, a rate that is within the range of the rates reported
in studies on RSA, not dealing with RA, that included a high
number of patients. In four of such studies the rate of revisions
was 4.5 % [34], 7.5 % [28], 12 % [13] and 14.8 % [27]. In this
review, infection was the cause of revision in four of eight
cases. This high infection rate in patients with RA is likely
related to the disturbances of the immune system responsible
for this autoimmune disease. Rheumatoid patients thus need
special precautions in this regard, such as the administration of
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antibiotics one or more days before surgery [45] or the use of
antibiotic-loaded bone cement, able to reduce the risk of in-
fection in shoulder arthroplasty [15].
The results of this review appear to indicate that the clinical
outcomes of RSA in RA are comparable to those obtained in
patients with massive rotator cuff tears with or without ar-
thropathy. Anyhow, it should be highlighted that the follow-
up of many patients in this study was relatively short to eval-
uate the implant-related adverse events (revision, severe
glenoid loosening), which tend to increase in number with
increasing time from surgery [28, 54]. However, the survival
rate of the implant in the entire group of studies was 90.8 % at
a mean of almost five years, which is an encouraging figure,
though not so high as to give the patients sound certainty of
long-term good results. Our findings support the belief of
Favard et al. [27] that young patients with RA are better can-
didates for HA, whereas an RSA can be indicated in older
subject as, on the other hand, it is still the rule in the most
common indications for RSA.
Conflict of interest The authors declare that they have no conflict of
interest.
References
1. Sperling JW, Cofield RH, Schleck CD, Harmsen WS (2007)
Total shoulder arthroplasty versus hemiarthroplasty for rheuma-
toid arthritis of the shoulder: results of 303 consecutive cases. J
Should Elbow Surg 16:683–690
2. Field LD, Dines DM, Zabinski SJ, Warren RF (1997)
Hemiarthroplasty of the shoulder for rotator cuff arthropathy. J
Should Elbow Surg 6:18–23
3. Lehtinen JT, Belt EA, Lybäck CO, Kauppi MJ et al (2000)
Subacromial space in the rheumatoid shoulder: a radiographic 15-
year follow-up study of 148 shoulders. J Should Elbow Surg 9:
183–187
4. Franklin JL, BarrettWP, Jackins SE,Matsen FA 3rd (1988) Glenoid
loosening in total shoulder arthroplasty. Association with rotator
cuff deficiency. J Arthroplasty 3:39–46
5. Baulot E, Garron E, Grammont PM (1999) Grammont prosthesis in
humeral head osteonecrosis. Indications-results. Acta Orthop Belg
65(Suppl 1):109–115
6. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group
(2009) Preferred reporting items for systematic reviews and meta-
analyses: the PRISMA statement. BMJ 339:b2535. doi:10.1136/
bmj.b2535
7. Abdel MP, Hattrup SJ, Sperling JW, Cofield RH et al (2013)
Revision of an unstable hemiarthroplasty or anatomical total shoul-
der replacement using a reverse design prosthesis. Bone Joint J 95
Br:668–672. doi:10.1302/0301-620X.95B5.30964
8. Baulot E, Chabernaud D, Grammont PM (1995) [Results of
Grammont’s inverted prosthesis in omarthritis associated with ma-
jor cuff destruction. Apropos of 16 cases]. Acta Orthop Belg
61(Suppl 1):112–119
9. Boileau P, Watkinson D, Hatzidakis AM, Hovorka I (2006) Neer
Award 2005: the Grammont reverse shoulder prosthesis: results in
cuff tear arthritis, fracture sequalae, and revision arthroplasty. J
Should Elbow Surg 15:527–540. doi:10.1016/j.se.2006.01.003
10. Boulahia A, Edwards TB, Walch G, Baratta RV et al (2002) Early
results of a reverse design prosthesis in the treatment of arthritis of
the shoulder in elderly patients with a large rotator cuff tear.
Orthopedics 25:129–133
11. Castagna A, Delcogliano M, de Caro F, Ziveri G et al (2013)
Conversion of shoulder arthroplasty to reverse implants: clinical
and radiological results using a modular system. Int Orthop 37:
1297–1305. doi:10.1007/s00264-013-1907-4
12. Cuff D, Pupello D, Virani N, Levy J et al (2008) Reverse shoulder
arthroplasty for the treatment of rotator cuff deficiency. J Bone Joint
Surg Am 90:1244–1251. doi:10.2106/JBJS.G.00775
13. Frankle M, Siegal S, Pupello D, Saleem A et al (2005) The Reverse
shoulder prosthesis for glenohumeral arthritis associated with se-
vere rotator cuff deficiency. A minimum two-year follow-up study
of sixty patients. J Bone Joint Surg Am 87:1697–1705
14. Levy JC, Virani N, Pupello D, Frankle M (2007) Use of reverse
shoulder prosthesis for the treatment of failed hemiarthroplasty in
patients with glenohumeral arthritis and rotator cuff deficiency. J
Bone Joint Surg (Br) 89:189–195. doi:10.1302/0301-620X.89B2.
18161
15. Nowinski RJ, Gillespie RJ, Shishani Y, Cohen B et al (2012)
Antibiotic-loaded bone cement reduces deep infection rates for pri-
mary reverse total shoulder arthroplasty: a retrospective, cohort
study of 501 shoulders. J Should Elbow Surg 21:324–328. doi:
10.1016/j.jse.2011.08.072
16. Ortmaier R, Resch H, Matis N, Blocher M et al (2013) Reverse
shoulder arthroplasty in revision of failed shoulder arthroplasty—
outcome and follow-up. Int Orthop 37:67–75. doi:10.1007/s00264-
012-1742-z
17. Patel DN, Young B, Onyekwelu I, Zuckerman JD et al (2012)
Reverse total shoulder arthroplasty for failed shoulder arthroplasty.
J Should Elbow Surg 21:1478–1483. doi:10.1016/j.jse.2011.
11.004
18. Rahme H, Mattsson P, Wikblad L, Larsson S (2006) Cement and
press-fit humeral stem fixation provides similar results in rheuma-
toid patients. Clin Orthop Relat Res 448:28–32
19. Richards J, Inacio MCS, Beckett M, Navarro RA et al (2014)
Patient and procedure-specific risk factors for deep infection after
primary shoulder arthroplasty. Clin Orthop Relat Res 472:2809–
2815. doi:10.1007/s11999-014-3696-5
20. Schairer WW, Zhang AL, Feeley BT (2014) Hospital readmissions
after primary shoulder arthroplasty. J Should Elbow Surg 23:1349–
1355. doi:10.1016/j.jse.2013.12.004
21. Seebauer L, Walter W, Keyl W (2005) Reverse total shoulder
arthroplasty for the treatment of defect arthropathy. Oper Orthop
Traumatol 17:1–24
22. Vanhove B, Beugnies A, Grammont PM (2004) Reverse shoulder
prosthesis for rotator cuff arthropathy. A retrospective study of 32
cases. Acta Orthop Belg 70:219–233
23. Walch G, Boileau P, Noël E (2010) Shoulder arthroplasty: evolving
techniques and indications. Joint Bone Spine 77:501–505. doi:10.
1016/j.jbspin.2010.09.004
24. Walker M, Willis MP, Brooks JP, Pupello D et al (2012) The use of
the reverse shoulder arthroplasty for treatment of failed total shoul-
der arthroplasty. J Should Elbow Surg 21:514–522. doi:10.1016/j.
jse.2011.03.006
25. Werner CM, Steinmann PA, Gilbart M, Gerber C (2005) Treatment
of painful pseudoparesis due to irreparable rotator cuff dysfunction
with the Delta III reverse-ball-and-socket total shoulder prosthesis.
J Bone Joint Surg Am 87:1476–1486. doi:10.2106/JBJS.D.02342
26. Dillon MT, Inacio MC, Burke MF, Navarro RA et al (2013)
Shoulder arthroplasty in patients 59 years of age and younger. J
Should Elbow Surg 22:1338–1344. doi:10.1016/j.jse.2013.01.029
International Orthopaedics (SICOT)
Author's personal copy
27. Favard L, Katz D, Colmar M, Benkalfate Tet al (2012) Total shoul-
der arthroplasty—arthroplasty for glenohumeral arthropathies: re-
sults and complications after a minimum follow-up of 8 years ac-
cording to the type of arthroplasty and etiology. Orthop Traumatol
Surg Res 98:541–547
28. Guery J, Favard L, Sirveaux F, Oudet D et al (2006) Reverse total
shoulder arthroplasty. Survivorship analysis of eighty replacements
followed for five to ten years. J Bone Joint Surg Am 88:1742–1747
29. Jiang JJ, Toor AS, Shi LL, Koh JL (2014) Analysis of perioperative
complications in patients after total shoulder arthroplasty and re-
verse total shoulder arthroplasty. J Should Elbow Surg 23:1852–
1859. doi:10.1016/j.jse.2014.04.008
30. Lévigne C, Boileau P, Favard L, Gaeaud P et al (2008) Scapular
notching in reverse shoulder arthroplasty. J Should Elbow Surg 17:
925–935. doi:10.1016/j.jse.2008.02.010
31. Muh SJ, Streit JJ, Wanner JP, Lenarz CJ et al (2023) Early follow-
up of reverse total shoulder arthroplasty in patients sixty years of
age or younger. J Bone Joint Surg Am 95:1877–1883. doi:10.2106/
JBJS.L.10005
32. Sershon RA, Van Thiel GS, Lin EC, McGill KC et al (2014)
Clinical outcomes of reverse total shoulder arthroplasty in patients
aged younger than 60 years. J Should Elbow Surg 23:395–400. doi:
10.1016/j.jse.2013.07.047
33. Walch G, Bacle G, Lädermann A, Nové-Josserand L et al (2012)
Do the indications, results, and complications of reverse shoulder
arthroplasty change with surgeon’s experience? J Should Elbow
Surg 21:1470–1477. doi:10.1016/j.jse.2011.11.010
34. Wall B, Nové-Josserand L, O’Connor DP, Edwards TB et al (2007)
Reverse total shoulder arthroplasty: a review of results according to
etiology. J Bone Joint Surg Am 89:1476–1485. doi:10.2106/JBJS.
F.00666
35. Mahmood A, Malal JJ, Waseem M (2013) Reverse shoulder
arthroplasty—a literature review. Open Orthop J 7:366–372. doi:
10.2174/1874325001307010366
36. Smith CD, Guyver P, Bunker TD (2012) Indications for reverse
shoulder replacement: a systematic review. J Bone Joint Surg (Br)
94:577–583. doi:10.1302/0301-620X.94B5.27596
37. Khan WS, Longo UG, Ahrens PM, Denaro V et al (2011) A sys-
tematic review of the reverse shoulder replacement in rotator cuff
arthropathy, rotator cuff tears, and rheumatoid arthritis. Sports Med
Arthros 19:366–379. doi:10.1097/JSA.0b013e318224e44e
38. Hedtmann A, Werner A (2007) [Shoulder arthroplasty in rheuma-
toid arthritis]. Orthopade 11:1050–1061
39. Wiater JM, FabingMH (2009) Shoulder arthroplasty:prosthetic op-
tions and indications. J Am Acad Orthop Surg 17:415–425
40. Irlenbusch U, Forke L, Fuhrmann U, Gebhardt K et al (2010)
Establishing the differential indication for anatomical and reversed
shoulder endoprostheses in rheumatoid arthritis. Z Rheumatol 69:
240–249. doi:10.1007/s00393-009-0441-7
41. John M, Pap G, Angst F, Flury MP et al (2010) Short-term results
after reversed shoulder arthroplasty (Delta III) in patients with
rheumatoid arthritis and irreparable rotator cuff tear. Int Orthop
34:71–77. doi:10.1007/s00264-009-0733-1
42. Rittmeister M, Kerschbaumer F, Grammont PM (2001) Reverse
total shoulder arthroplasty in patients with rheumatoid arthritis
and nonreconstructible rotator cuff lesions. J Should Elbow Surg
10:17–22
43. Woodruff MJ, Cohen AP, Bradley JG (2003) Arthroplasty of the
shoulder in rheumatoid arthritis with rotator cuff dysfunction. Int
Orthop 27:7–10
44. Holcomb JO, Hebert DJ, Mighell MA, Dunning PE et al (2010)
Reverse shoulder arthroplasty in patients with rheumatoid
arthritis. J Should Elbow Surg 19:1076–1084. doi:10.1016/
j.jse.2009.11.049
45. Ekelund A, Nyberg R (2011) Can reverse shoulder arthroplasty be
used with few complications in rheumatoid arthritis? Clin Orthop
Relat Res 469:2483–2488. doi:10.1007/s11999-010-1654-4
46. Young AA, Smith MM, Bacle G, Moraga C et al (2011) Early
results of reverse shoulder arthroplasty in patients with rheumatoid
arthritis. J Bone Joint Surg Am 93:1915–1923. doi:10.2106/JBJS.J.
00300
47. Constant CR, Murley AH (1987) A clinical method of functional
assessment of the shoulder. Clin Orthop Relat Res 214:160–164
48. Larsen A, Dale K, Eek M (1997) Radiographic evaluation of rheu-
matoid arthritis and related conditions by standard reference films.
Acta Radiol Diagn (Stockh) 18:481–491
49. Lévigne C (2002) Classifications et évolutions radiographiques de
l’épaule rhumatoïde. Rev Rhum [Ed Fr] 69(Suppl 3):108–112
50. Valenti P, BoutensD, Nerot C (2001) Delta 3 reversed prosthesis for
osteoarthritis with massive rotator cuff tear: long term results
(>5 years). In: Walch G, Boileau P, Molé D (eds) 2000 shoulder
prostheses two to ten year follow-up. Sauramps Medical,
Montpellier, pp 253–259
51. Sirveaux F, Favard L, Oudet D, Huquet D et al (2004) Grammont
inverted total shoulder arthroplasty in the treatment of glenohumeral
osteoarthritis with massive rupture of the cuff. Results of a
multicentre study of 80 shoulders. J Bone Joint Surg (Br) 86:
388–395
52. Nolan BM, Ankerson E, Wiater JM (2011) Reverse total shoulder
arthroplasty improves function in cuff tear arthropathy. Clin Orthop
Relat Res 469:2476–2482. doi:10.1007/s11999-010-1683-z
53. Zumstein MA, Pinedo M, Old J, Boileau P (2011) Problems,
complications, reoperations, and revisions in reverse shoulder
arthroplasty: a systematic review. J Should Elbow Surg 20:
146–157. doi:10.1016/jse.2010.08.001
54. Scarlat MM (2013) Complications with reverse total shoulder
arthroplasty and recent evolutions. Int Orthop 37:843–851. doi:
10.1007/s00264-013-1832-6
55. De Biase CF, Ziveri G, Delcogliano M, De Caro F et al (2013) The
use of an eccentric glenosphere compared with a concentric
glenosphere in reverse total shoulder arthroplasty: two-year mini-
mum follow-up results. Int Orthop 37:1949–1955. doi:10.1007/
s00264-013-1947-9
International Orthopaedics (SICOT)
Author's personal copy
